Pharmacological modulation of PKR holds promise as an alternative treatment strategy for bacterial infections, but extensive in vivo studies must be conducted to assess the effects of PKR modulation on host survival and identify potential off-target effects. This evidence concerns the gene EIF2AK2 and bacterial infectious disease.